AF
AKRO

Advisornet Financial’s Akero Therapeutics AKRO Stock Holding History

Advisornet Financial’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-91
Closed -$4.32K – 2237
2025
Q3 		$4.32K Buy
+91
New +$4.41K ﹤0.01% 1732

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Advisornet Financial's AKRO Position: Q4 2025 in Review

Advisornet Financial sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 91 shares — an estimated $4.32K sold.

Advisornet Financial first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $4.32K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Advisornet Financial reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Advisornet Financial sold 91 Akero Therapeutics shares in Q4 2025, an estimated $4.32K.
  • Advisornet Financial first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Advisornet Financial's Akero Therapeutics position peaked at $4.32K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Advisornet Financial's 13F filing for Q4 2025, filed 20 Jan 2026.